Metabolomics for Distinguishing Cardiovascular Risk in Rheumatoid Arthritis Across Different Disease-Modifying Antirheumatic Drug Therapies
Our findings have aided in the identification of potential surrogate markers for assessing the burden of CVD in individuals with RA. Histidine may be of particular diagnostic importance in CVR assessment in RA.
Authors
- Steffen Heelemann (ORCID: https://orcid.org/0000-0001-5104-8774)
- Oliver Ritter (ORCID: https://orcid.org/0000-0003-4172-9378)
- Chressen Catharina Remus (ORCID: https://orcid.org/0000-0003-0454-127X)
- Werner Dammermann (ORCID: https://orcid.org/0000-0001-6847-3769)
- Daniel Patschan (ORCID: https://orcid.org/0000-0002-6914-5254)
- Inga Claus
- Meike Hoffmeister (ORCID: https://orcid.org/0000-0003-3561-5286)
- Selina Strathmeyer (ORCID: https://orcid.org/0009-0006-6074-5268)
- Susann Patschan
Institutions
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Universitätsklinikum Brandenburg an der Havel (DE)
Publication Details
- Journal
- Journal of Clinical Medicine Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.14740/jocmr6145
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67